Skip to main content
. 2017 Feb 28;41(4):475–482. doi: 10.1038/ijo.2016.230

Table 1. Characteristics of the studies included in the meta-analysis.

Study EG
CG
BMI (percentile or kg m−2) Intervention characteristics
Assessment
  n Age (years) Type n Age (years)   Duration (weeks) Frequency (Se/W) Se duration (min) Intensity Compliance (%)  
Balagopal et al.19 8 15.6 Aerobic+Resistance 7 15.9 ⩾p97 12 3 45 NR NR Leptin
Balagopal et al.13 8 15.6 Aerobic+Resistance 7 15.9 ⩾p97 12 3 45 NR NR Adiponectin
Chae et al.27 19 10.4 Aerobic+Resistance 19 10.6 ⩾p97 12 2 90 NR NR Adiponectin
Fazelifar et al.28 12 11–13 Aerobic+Resistance 12 11–13 ⩾28 12 3 10–30 50–85 HRmax NR Adiponectin
Jeon et al.29 8 11.0 Aerobic+Resistance 7 11.0 ⩾p85 12 2 50 55–75 HRmax NR Adiponectin
Karacabey30 20 11.8 Aerobic 20 11.2 >30 12 3 30–65 60–65 HRmax NR Leptin
Kelly et al.31 9 10.8 Aerobic 10 11.0 ⩾p85 8 4 30 50–60 HRmax NR Leptin, Adiponectin, Resistin
Kim et al.32 14 17.0 Aerobic 12 17.0 NR 6 5 40 NR NR Adiponectin
Kim et al.37 18 17.6 Aerobic 12 17.4 ⩾25 12 5 50 NR NR Adiponectin
Lee et al.33 11 16.9 Aerobic 7 16.9 ⩾25 12 3 30–40 60–80 HRmax NR Visfatin
Nunes et al.38 17 16.8 Aerobic+Resistance 8 15.4 ⩾p95 24 4 60 60–100 VO2peak NR Adiponectin
Park et al.34 15 12.1 Aerobic+Resistance 14 12.2 ⩾p85 12 3 80 50–70 HRreserve 90 Leptin, Adiponectin
Racil et al.35 11 11 15.6 16.3 Anerobic Aerobic 12 15.9 ⩾p97 12 4 20 100–110 VO2peak 70–80 VO2peak NR Adiponectin
Vasconcellos et al.36 10 14.1 Aerobic 10 14.8 ⩾2 s.d. 12 3 60 84.8 HRmax NR Leptin, Adiponectin, Resistin

Abbreviations: CG, control group; EG, experimental group; HIIT, high-intensity interval training; HR, heart rate; MIIT, moderate-intensity interval training; NR, not reported; p, percentile; Se, session; W, week.